| (-)-β-Peltatin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.45% |
| Isoegomaketone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (2S,3R,4S)-ASX-173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| (rac)-Talazoparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1,3,5-Tricaffeoylquinic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1,5-Isoquinolinediol |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.14% |
| 13'-Carboxy-δ-tocopherol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2'-Nitroflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 2-Chlorohexadecanoic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Alisol B 23-acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| 2H-Indazole-7-carboxamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 3',4'-Dihydroxyacetophenone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| 3',4'-Dimethoxyflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.63% |
| 3-Aminobenzamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| 3-Methoxybenzamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| 4'-Methoxychalcone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| 4,4′-Secalonic acid D |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fluorescent brightener 71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 4-Aminonaphthalimide |
|
|
|
|
|
|
|
|
|
|
|
|
|
≥97.0% |
| 2-Methylquinazolin-4-ol |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| 4F-DDC |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 5,7,4'-Trimethoxyflavone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.21% |
| 5,7-Dihydroxychromone |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| 5-AIQ |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| 5-AIQ hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 6(5H)-Phenanthridinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| 7-Methylguanine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| 8-ET-NAD+ sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 8-Chloroquinazolin-4-ol |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.44% |
| A-620223 |
|
|
|
|
|
|
|
|
|
|
|
|
|
96.09% |
| A-620223 succinate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| A-966492 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.00% |
| PARP-2/1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Acrofolione A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AD-2646 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ADP-ribose/PARP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ADPRP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AG14361 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.42% |
| AKT-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ALK-IN-26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Amelparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.17% |
| Amelparib hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.37% |
| Aniline mustard |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| Anticancer agent 137 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 201 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 304 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.58% |
| Anticancer agent 64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Anticancer agent 71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-104 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-169 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-170 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-214 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Antitumor agent-72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| API-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.62% |
| Apoptosis inducer 34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| Apoptosis inducer 45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ARCher-142 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ARI-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.16% |
| ART-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.91% |
| ARTD10/PARP10-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ARTD10/PARP10-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ARTD3/PARP3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| ASP3026 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| ASX-173 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.47% |
| Atiprimod |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATR/PARP1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ATWLPPRAANLLMAAS |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AZ0108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| AZ3391 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.03% |
| AZ6102 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| AZ9482 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| AZD-2461 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| AZD-9574-acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| Basroparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.91% |
| Bax activator-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Bcl-2/Mcl-1-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benadrostin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Benzamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Benzamide-15N |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.87% |
| Benzo[c][1,8]naphthyridin-6(5H)-one |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BER-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BGP-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.57% |
| BIBD-300 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BIM-46174 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Biotin-NAD+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BM-1244 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| BPA-B9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.50% |
| BR102375 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRCA1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BRCA1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.12% |
| BRD4-IN-41 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BSI-001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BSI-401 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BTK-IN-47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BV02 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| BWA-6047 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BYK 49187 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| BYK204165 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Cajanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Calactin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cardanol monoene |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| Cathepsin-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDK9-IN-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDK9-IN-47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CDK9/PARP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CEP-6800 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CEP-8983 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CEP-9722 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Chlorin e6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.51% |
| Chlorin e6 (solution) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CHNQD-00824 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CHNQD-01426 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cimicifugic acid A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CQ-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CT-179 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| CU-TZD-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| CW-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dammarenediol II |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| DB008 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.47% |
| dCDK9-202 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.74% |
| DDO3602 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Dehydrocorydaline (hydroxyl) |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.52% |
| DiPT-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DLC-50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DP-C-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.15% |
| DPQ |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| DPQ hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| DR2313 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| E7016 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.11% |
| EAPB0503 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EB-47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| EB-47 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.58% |
| Echinoside A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EGFR-IN-197 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EGFR/PARP-1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| EXQ-2d |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FeTMPyP |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| FGFR-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| FLC-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fluorescein-NAD+ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Fluorescein-NAD+ sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.4% |
| FMP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| G-631 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| G007-LK |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| G244-LM |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.32% |
| GeA-69 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| GM-90257 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.90% |
| Gomisin N |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Gossypin |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.29% |
| GPI 15427 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| GPS167 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HDAC-IN-91 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HER2-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HER4/HER2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HL435 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| HYDAMTIQ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ICA-1S |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ICD inducer-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IDO1-IN-34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IHMT-BMX-068 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| INH2BP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Iniparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| INO-1001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.86% |
| INO-1001 mesylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IPH10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| IRF1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| IRF1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| iRucaparib-AP6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.03% |
| iRucaparib-TP3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Isocryptotanshinone |
|
|
|
|
|
|
|
|
|
|
|
|
|
98% |
| Itareparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| iVeliparib-AP6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| JP-11646 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.74% |
| JQAD1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.24% |
| JW 55 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| K-756 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.25% |
| KB-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KCL-440 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KMR-206 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.86% |
| KSQ-4279 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| KSQ-4279 gentisate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| KU-0058684 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.54% |
| KU-0058948 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| KU-0058948 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| KWZY-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L-2286 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LD5097 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Lerzeparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LIB3S0280 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| LL-K12-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.42% |
| Lotixparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LS-75 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.31% |
| Lss-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| LT-626 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MAPK-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MC2050 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Mcl-1-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MD6a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ME0328 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.64% |
| Mefuparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| MHY219 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MK-2048 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MKI-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MMRi6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| MN-64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| MNK/PIM-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MRTX849-amide-C4-(o)-carborane |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MS6076 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| MSC2504877 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.25% |
| Mulberrofuran G |
|
|
|
|
|
|
|
|
|
|
|
|
|
97.86% |
| Mycophenolic Acid-d3 Acyl-Beta-D-glucuronide |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Myrothecine A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| N-Descyclopropanecarbaldehyde Olaparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| NCP26 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NCT-TFP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NDs-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nesuparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| Nesuparib hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NEURL1B-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Niraparib (R-enantiomer) |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.86% |
| NMS-P118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.54% |
| NMS-P515 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.18% |
| NSC 146109 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| NSC-368262 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NSC666715 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NU 1085 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NU1025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| NU1064 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nudifloramide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Nudifloramide-13C,d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nudifloramide-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.43% |
| Nudifloramide-d6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Nur77 modulator 5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| NVP-TNKS656 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| Ola-NC-SS-PEG-Lap |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| OM-153 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.30% |
| OM-1700 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Orsellinic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.36% |
| OUL232 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| OUL245 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| OUL312 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.20% |
| OUL35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Oxychlororaphine |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.63% |
| Pamiparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| PARP-1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-1-IN-13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| PARP-1-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| PARP-1-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| PARP-1/2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-1/2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-1/2-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-1/2/7-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-1/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-1/Proteasome-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.56% |
| PARP-2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP-2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP/EZH2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP/EZH2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP/HDAC-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP/PI3K-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| PARP/VEGFR3-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1 degrader 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1 degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp1 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1 PROTAC 180055 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.90% |
| Parp1 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-11 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.42% |
| PARP1-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-27 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.60% |
| PARP1-IN-33 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.02% |
| PARP1-IN-34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-35 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-36 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-38 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-39 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-40 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-42 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-43 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-46 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-47 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-5 dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
97.56% |
| PARP1-IN-50 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-52 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-53 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-55 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.03% |
| PARP1-IN-6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1-IN-7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| PARP1-IN-8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| PARP1-IN-9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/2-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/2/TNKS1/2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.66% |
| PARP1/BRD4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/BRD4-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/BRD4-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/c-Met-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/c-Met-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/c-Met-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/CDK12-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/ERK IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/EZH2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/NAMPT-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/NAMPT-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP1/PKM2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP10 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp10 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp10 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP10-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP10-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.02% |
| PARP10-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.72% |
| PARP10-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP10/15-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
95.04% |
| PARP10/15-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.92% |
| PARP10/15-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.23% |
| PARP11 inhibitor ITK7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| PARP14 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP14 inhibitor 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP14 inhibitor 2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP14 inhibitor H10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.46% |
| Parp14 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp14 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP2 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp2 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp2 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP3 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp3 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp3 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP4 Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp4 Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Parp4 Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-IN-12 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-IN-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.03% |
| PARP7-IN-16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
95.0% |
| PARP7-IN-16 free base |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.40% |
| PARP7-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| PARP7-IN-18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-IN-19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-IN-21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-IN-22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.59% |
| PARP7-IN-23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-IN-24 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-IN-25 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7-probe-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARP7/HDACs-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PARPi-FL |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| PARPYnD |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.86% |
| PC8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PCIP-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PD128763 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PFKFB4-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Physcion 8-O-β-D-glucopyranoside |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.21% |
| PI-1840 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.78% |
| PI3K/AKT-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PIM-1/HDAC-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PJ34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.66% |
| PJ34 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.81% |
| Polθ/PARP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.08% |
| Procyanidin B2-3'-O-gallate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Prostaglandin A2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.9% |
| PROTAC BCL6/GSPT1 Degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC BET Degrader-15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC EZH2 Degrader-44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC FTO degrader 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC MLKL Degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC PARP/EGFR ligand 1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC PARP1 degrader |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| PROTAC PARP1 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| PROTAC PARP1 degrader-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC PARP1 degrader-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC PARP1 degrader-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| PROTAC PARP2 degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
95.86% |
| PROTAC survivin degrader-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quinalizarin |
|
|
|
|
|
|
|
|
|
|
|
|
|
97.23% |
| R9-caPep |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RBN-2397 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| RBN-3143 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.29% |
| RBN010860 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RBN012759 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.33% |
| RBN012811 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.79% |
| rel-PROTAC PARP1 degrader |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.99% |
| RK-287107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| RK-582 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.05% |
| RMC-7977 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.48% |
| RO5068760 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ROR1-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RPS6-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| RTx-161 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Ru3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rucaparib camsylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| S-Petasin |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Santamarine |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.85% |
| Saruparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Satratoxin H |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.7% |
| Schisandronic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Senaparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| Senaparib hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Simmiparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.01% |
| Sino-C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SK-575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| SK-575-NEG |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SKLB70326 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| SRSF1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ST7710AA1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Stenoparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Stigmast-5-en-3-ol |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| STING-IN-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| STK899704 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Sweroside |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.76% |
| Talazoparib-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tambiciclib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| Tambiciclib dimaleate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| Tankyrase-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.06% |
| Tankyrase-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tankyrase-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tankyrase-IN-5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Taurodeoxycholic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| TC-E 5001 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TDI-012804 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Telapristone acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TH-407a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TH5427 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Thalidomide-piperidine-C-Pip-C2-Pip-C2-OH |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Theophylline-platinum(IV) prodrug-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TIPARP Human Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tiparp Mouse Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tiparp Rat Pre-designed siRNA Set A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TIPARP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TIQ-A |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| TLSC702 |
|
|
|
|
|
|
|
|
|
|
|
|
|
95.61% |
| TMLB-C16 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.27% |
| TNKS 22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TNKS modulator-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TNKS-2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
95.03% |
| TNKS-2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.47% |
| TNKS-2-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TNKS-2-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TNKS-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.55% |
| TNKS-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TNKS-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TNKS-IN-4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TNKS1/2-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.24% |
| TNKS1/2-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TOPOI/PARP-1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TOPOI/PARP-1-IN-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Topoisomerase I/II inhibitor 8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| TP-110 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trifloxystrobin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.49% |
| Trijuganone C |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Trilexium |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.70% |
| Tubulin polymerization-IN-68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tubulin/PARP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Tubulin/PARP1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UKTT15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.29% |
| ULK1-IN-3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UNPD139734 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| UPF 1069 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.02% |
| UPF-1035 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| USP7-IN-20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VEGFR/PARP-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Venadaparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.11% |
| Venadaparib hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VPC-70063 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Vrucaparib-TP4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| VS1150 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| WD2000-012547 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| WIKI4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.61% |
| WP-1034 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XAV-939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| XAV-939 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| XW-17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YCH1899 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.39% |
| YCH3292 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YCH3971 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| YTHDC1-IN-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.44% |
| YTHu78 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZINC000081009201 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ZINC43120769 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| α-Santalol |
|
|
|
|
|
|
|
|
|
|
|
|
|
97.62% |
| Beta-Sitosterol (purity>98%) |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Triclabendazole |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.36% |
| Talazoparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.85% |
| (8R,9S)-Talazoparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.28% |
| Talazoparib tosylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Flavokawain C |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.53% |
| Picolinamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Caudatin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Purine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.83% |
| Rehmannioside A |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Quinidine-13C, d2 hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quinidine hydrochloride monohydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.97% |
| Quinidine hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Olaparib-d4-1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.82% |
| Olaparib-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.37% |
| Olaparib-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.88% |
| Olaparib-d4-2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Olaparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| AC-45594 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.94% |
| Niraparib hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.41% |
| Niraparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Niraparib-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Niraparib tosylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |
| Fucosterol |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.27% |
| Patritumab |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.28% |
| Fluzoparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Arenobufagin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.82% |
| Taurodeoxycholate sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.80% |
| Taurodeoxycholat-d4 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Taurodeoxycholate-d6 sodium |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.4% |
| Sodium taurodeoxycholate hydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
97.0% |
| Rucaparib-d3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rucaparib-d8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rucaparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.96% |
| Rucaparib monocamsylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.91% |
| Rucaparib hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rucaparib phosphate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.65% |
| Rucaparib tartrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Rucaparib acetate |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Daphnetin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Niraparib tosylate hydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| Sorafenib tosylate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Proadifen hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.95% |
| Mefuparib hydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.62% |
| Dehydrocorydaline chloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.75% |
| Cyproheptadine hydrochloride sesquihydrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Dehydrocorydaline nitrate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Sorafenib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Veliparib |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.77% |
| Veliparib dihydrochloride |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.98% |
| Polyporenic acid C |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.81% |
| Dehydrocorydaline |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.42% |
| Sulfabenzamide |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.68% |
| Sulfabenzamide-d4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.74% |
| Benzamide-d5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Solanesol |
|
|
|
|
|
|
|
|
|
|
|
|
|
98.0% |
| Stem bromelain |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Hellebrigenin |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| Dracorhodin perchlorate |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.02% |
| Epifriedelanol |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.69% |
| Peiminine |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.89% |
| Coenzyme Q0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.79% |
| Jujuboside B |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.92% |
| Paris saponin VII |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.84% |
| Continentalic acid |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.72% |
| Homoeriodictyol |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.86% |
| Flavokawain B |
|
|
|
|
|
|
|
|
|
|
|
|
|
99.99% |